Premium
Subthreshold micropulse photocoagulation with true yellow 577nm diode laser for macular oedema
Author(s) -
FRUSCHELLI M,
SPARAGNA MC,
DENARO R,
MENICACCI F,
ESPOSTI G,
ESPOSTI PL
Publication year - 2012
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/j.1755-3768.2012.4727.x
Subject(s) - medicine , macular edema , ophthalmology , diabetic retinopathy , branch retinal vein occlusion , laser coagulation , serous fluid , subthreshold conduction , retinal , visual acuity , retinal vein , diabetes mellitus , surgery , endocrinology , physics , transistor , quantum mechanics , voltage
Purpose Subthreshold, or tissue sparing, Diode Micropulse Photocoagualtion (SDM) is a treatment used to produce a therapeutic effect without inducing detectable intraretinal damage. Actually treatment options are available for diabetic macular edema (DME), proliferative diabetic retinopathy (PDR), central serous chorioretinopathy (CSR), macular edema secondary to branch retinal vein occlusion (BRVO), and even glaucoma. Methods We used micropulse technology with 577nm yellow diode laser to produce a therapeutic effect without inducing intraretinal damage detectable on clinical examination during or after the treatment. All patients were affected by clinically significative macular edema (CSME) due to diabetic retinopathy, venous branch retinal occlusion and central serous retinopathy. Results Controls prefomed at 1, 3 and 6 months showed no detectable retinal scars in any case. Foveal thickness decreased in all patients, visual acuity remained stable (<10 ETDRS letters) or improved (≥10 ETDRS letters). Conclusion The results of our study indicate that, in the treatment of CSME due to PDR, BRVO and CSR,SDM photocoagulation is at least as effective as conventional photocoagulation without any clinically discernible evidence of laser‐induced iatrogenic damage.